299 related articles for article (PubMed ID: 19139320)
1. Osteoporosis case manager for patients with hip fractures: results of a cost-effectiveness analysis conducted alongside a randomized trial.
Majumdar SR; Lier DA; Beaupre LA; Hanley DA; Maksymowych WP; Juby AG; Bell NR; Morrish DW
Arch Intern Med; 2009 Jan; 169(1):25-31. PubMed ID: 19139320
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of a multifaceted intervention to improve quality of osteoporosis care after wrist fracture.
Majumdar SR; Lier DA; Rowe BH; Russell AS; McAlister FA; Maksymowych WP; Hanley DA; Morrish DW; Johnson JA
Osteoporos Int; 2011 Jun; 22(6):1799-808. PubMed ID: 20878389
[TBL] [Abstract][Full Text] [Related]
3. Economic evaluation of a population-based osteoporosis intervention for outpatients with non-traumatic non-hip fractures: the "Catch a Break" 1i [type C] FLS.
Majumdar SR; Lier DA; Hanley DA; Juby AG; Beaupre LA;
Osteoporos Int; 2017 Jun; 28(6):1965-1977. PubMed ID: 28275838
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of two inexpensive postfracture osteoporosis interventions: results of a randomized trial.
Majumdar SR; Lier DA; Leslie WD
J Clin Endocrinol Metab; 2013 May; 98(5):1991-2000. PubMed ID: 23596140
[TBL] [Abstract][Full Text] [Related]
5. Cost-Effectiveness of Osteoporosis Interventions to Improve Quality of Care After Upper Extremity Fracture: Results From a Randomized Trial (C-STOP Trial).
Majumdar SR; Lier DA; McAlister FA; Johnson JA; Rowe BH; Beaupre LA
J Bone Miner Res; 2019 Jul; 34(7):1220-1228. PubMed ID: 30779861
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of osteoporosis interventions for 'incidental' vertebral fractures.
Majumdar SR; Lier DA; McAlister FA; Rowe BH; Siminoski K; Hanley DA; Russell AS; Johnson JA
Am J Med; 2013 Feb; 126(2):169.e9-17. PubMed ID: 23331449
[TBL] [Abstract][Full Text] [Related]
7. Persistence, reproducibility, and cost-effectiveness of an intervention to improve the quality of osteoporosis care after a fracture of the wrist: results of a controlled trial.
Majumdar SR; Johnson JA; Lier DA; Russell AS; Hanley DA; Blitz S; Steiner IP; Maksymowych WP; Morrish DW; Holroyd BR; Rowe BH
Osteoporos Int; 2007 Mar; 18(3):261-70. PubMed ID: 17086470
[TBL] [Abstract][Full Text] [Related]
8. Facilitated bone mineral density testing versus hospital-based case management to improve osteoporosis treatment for hip fracture patients: additional results from a randomized trial.
Morrish DW; Beaupre LA; Bell NR; Cinats JG; Hanley DA; Harley CH; Juby AG; Lier DA; Maksymowych WP; Majumdar SR
Arthritis Rheum; 2009 Feb; 61(2):209-15. PubMed ID: 19177538
[TBL] [Abstract][Full Text] [Related]
9. A coordinator program in post-fracture osteoporosis management improves outcomes and saves costs.
Sander B; Elliot-Gibson V; Beaton DE; Bogoch ER; Maetzel A
J Bone Joint Surg Am; 2008 Jun; 90(6):1197-205. PubMed ID: 18519311
[TBL] [Abstract][Full Text] [Related]
10. Use of a case manager to improve osteoporosis treatment after hip fracture: results of a randomized controlled trial.
Majumdar SR; Beaupre LA; Harley CH; Hanley DA; Lier DA; Juby AG; Maksymowych WP; Cinats JG; Bell NR; Morrish DW
Arch Intern Med; 2007 Oct; 167(19):2110-5. PubMed ID: 17954806
[TBL] [Abstract][Full Text] [Related]
11. Dedicated Perioperative Hip Fracture Comanagement Programs are Cost-effective in High-volume Centers: An Economic Analysis.
Swart E; Vasudeva E; Makhni EC; Macaulay W; Bozic KJ
Clin Orthop Relat Res; 2016 Jan; 474(1):222-33. PubMed ID: 26260393
[TBL] [Abstract][Full Text] [Related]
12. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
[TBL] [Abstract][Full Text] [Related]
13. Pharmacoeconomic analysis of osteoporosis treatment with risedronate.
Brecht JG; Kruse HP; Felsenberg D; Möhrke W; Oestreich A; Huppertz E
Int J Clin Pharmacol Res; 2003; 23(4):93-105. PubMed ID: 15224498
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic Fixation Can Be Cost-effective in Preventing a Contralateral Bisphosphonate-associated Femur Fracture.
Jiang SY; Kaufman DJ; Chien BY; Longoria M; Shachter R; Bishop JA
Clin Orthop Relat Res; 2019 Mar; 477(3):480-490. PubMed ID: 30394950
[TBL] [Abstract][Full Text] [Related]
15. Economic benefits of self-management education in COPD.
Bourbeau J; Collet JP; Schwartzman K; Ducruet T; Nault D; Bradley C
Chest; 2006 Dec; 130(6):1704-11. PubMed ID: 17166985
[TBL] [Abstract][Full Text] [Related]
16. Cost effectiveness of ibandronate for the prevention of fractures in inflammatory bowel disease-related osteoporosis: cost-utility analysis using a Markov model.
Kreck S; Klaus J; Leidl R; von Tirpitz C; Konnopka A; Matschinger H; König HH
Pharmacoeconomics; 2008; 26(4):311-28. PubMed ID: 18370566
[TBL] [Abstract][Full Text] [Related]
17. Expedited Operative Care of Hip Fractures Results in Significantly Lower Cost of Treatment.
Judd KT; Christianson E
Iowa Orthop J; 2015; 35():62-4. PubMed ID: 26361446
[TBL] [Abstract][Full Text] [Related]
18. A 3i hip fracture liaison service with nurse and physician co-management is cost-effective when implemented as a standard clinical program.
Beaupre LA; Lier D; Smith C; Evens L; Hanson HM; Juby AG; Kivi P; Majumdar SR;
Arch Osteoporos; 2020 Jul; 15(1):113. PubMed ID: 32699946
[TBL] [Abstract][Full Text] [Related]
19. Cost effectiveness of denosumab versus oral bisphosphonates for postmenopausal osteoporosis in the US.
Parthan A; Kruse M; Yurgin N; Huang J; Viswanathan HN; Taylor D
Appl Health Econ Health Policy; 2013 Oct; 11(5):485-97. PubMed ID: 23868102
[TBL] [Abstract][Full Text] [Related]
20. Nurse case-manager vs multifaceted intervention to improve quality of osteoporosis care after wrist fracture: randomized controlled pilot study.
Majumdar SR; Johnson JA; Bellerose D; McAlister FA; Russell AS; Hanley DA; Garg S; Lier DA; Maksymowych WP; Morrish DW; Rowe BH
Osteoporos Int; 2011 Jan; 22(1):223-30. PubMed ID: 20358359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
